Laying the Foundation for Accelerated Tech Transfer

Chris Mayhew, Accenture
Scott Weiss, VP BD & Innovation, IDBS
Graeme Moody, Program Manager, BioPhorum
Teodor Leahu, Director of European Operations, IDBS
Bob Dvorak, Principal, BDMS Consulting

See all i3 2022 Sessions

About the Session:

More efficient acceleration of technology transfer has become increasingly important with the advent of precision medicine and increasing regulatory scrutiny into product quality, data integrity and the management of external partners. The primary driver for successful technology transfer is the sharing of accurate  and timely product and process knowledge between development and manufacturing and within manufacturing sites.

There are a number of hurdles to achieving the level of process knowledge required for successful technology transfer. Many of these emerge from subpar data management including reliance on spreadsheets and paper records, disparate digital data sources and geographically dispersed teams and sites. Join us for an engaging dialog between industry experts on how they overcame hurdles to achieve the level of process knowledge required for successful
technology transfer and how they are preparing for the shift from static tech transfer to dynamic, persistent and compliant knowledge sharing.

Watch the Session

You may also like these sessions:

See all i3 2022 Sessions
Chris Mayhew

With 25 years of software development background, Chris has been involved with industry of all shapes and sizes from start-up organisations to larger corporates, leading and managing teams. Over the past 10 years Chris has been growing his expertise in the scientific software arena having worked previously with Accelrys, now the BIOVIA brand with Dassault Systems, having been successfully promoted from a Solutions Consultant to Senior Manager along the way. Chris joined the Accenture Scientific Informatic Services team in 2019 as a Technology Consulting Manager. Since joining, Chris has provided invaluable insight into the Scientific Informatics landscape and dealing with complex, scientific data.

Scott Weiss

Scott Weiss is responsible for developing IDBS’ expanding network of technology and channel partners. He joined IDBS in 2004 and has held senior leadership roles in consultancy, product management and strategy. Prior to joining IDBS, Scott spent over 20 years in the pharmaceutical industry, where he led multiple drug-development programs from conceptualization to entry into clinical trials and has VP BD & Innovation, IDBS authored over 30 peer-reviewed scientific papers and patents. He obtained his PhD in Psychology from the University of Leeds, specializing in Neuroscience.

Graeme is based in Cambridge UK and has spent 25 years in the pharma industry as a drug metabolism and pharmacokinetics specialist, supporting oncology, respiratory/inflammation and diabetes research programmes. Graeme introduced some of the first robotic liquid handlers into AstraZeneca in the mid-90s. He is a Lean Sigma Master Blackbelt and has led numerous business improvement projects within R&D at AstraZeneca. Graeme has been with BioPhorum for 3
years running projects in the areas of Robotic Technologies, Continuous Biomanufacturing and New Technology Adoption.

Teodor has 14 years of expertise as a scientist in biotech process development, design, optimization, and validation. His successful track record building and managing technology roadmaps for GMP manufacturing, including software selection, qualification, and implementation, position him as a respected advisor on maximizing operational efficiency to accelerate scale-up, tech transfer, and commercial release. Before joining IDBS, Teo served as Process Development Scientist at Emergent BioSolutions, where he led science and technology for a newly developed orphan disease vaccine. Previously at Merck Healthcare, his roles spanned Bioprocess Development Scientist and Compliance Specialist for Downstream Processing. Teo holds a BS in Biomedical Engineering from Yale University and an MS in Biotechnology and Bioengineering from EPFL (Swiss Federal Institute of Bioengineering).

Bob Dvorak is one of the founding partners of BioPharma Data & Manufacturing Systems Consulting, LLC, which provides consulting services to companies in the biotech and pharma space, as well as to the vendors who serve those companies. His background includes over 35 years of work in Preclinical R&D laboratories, biotech startups, and software projects and product development with Siemens and Emerson.